The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 03, 2023

Filed:

Apr. 27, 2021
Applicants:

Ohio State Innovation Foundation, Columbus, OH (US);

Institute of Molecular Genetics As Cr, V.v.i., Prague, CZ;

Inventors:

Werner Tjarks, Columbus, OH (US);

Petr Bartunek, Prague, CZ;

David Sedlak, Prague, CZ;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/69 (2006.01); A61K 45/06 (2006.01); A61K 31/05 (2006.01); C07F 5/02 (2006.01); A61P 19/02 (2006.01); A61P 1/00 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/69 (2013.01); A61K 31/05 (2013.01); A61K 45/06 (2013.01); A61P 1/00 (2018.01); A61P 19/02 (2018.01); A61P 35/00 (2018.01); C07F 5/027 (2013.01); A61K 2300/00 (2013.01);
Abstract

Disclosed herein are compounds comprising dicarba-closo-dodecaborane. The compounds can be, for example, estrogen receptor beta (ERβ) agonists. In some examples, the compounds can be selective ERβ agonists. Also provided herein are methods of treating, preventing, or ameliorating cancer in a subject, suppressing tumor growth in a subject, treating an inflammatory disease in a subject, treating a neurodegenerative disease in a subject, treating a psychotropic disorder in a subject, or a combination thereof, by administering to a subject a therapeutically effective amount of one or more of the compounds or compositions described herein, or a pharmaceutically acceptable salt thereof.


Find Patent Forward Citations

Loading…